Mosaic ImmunoEngineering (CPMV) EBT Margin (2010 - 2011)
Mosaic ImmunoEngineering (CPMV) posted quarterly EBT Margin of 1414.17% for Q4 2011, up 141866.0% year-over-year from N/an in Q4 2010, and down 160.77% quarter-over-quarter from 542.31% in Q3 2011.
Mosaic ImmunoEngineering (CPMV) EBT Margin (2010 - 2011) Analysis & Trends
Mosaic ImmunoEngineering's EBT Margin history runs 2 years deep, the most recent figure standing at 1414.17% for Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 35.71% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -528.97% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 18.33% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 13.77% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -2.67% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 12.09% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -25.06% |
| 10 | Mosaic ImmunoEngineering | 527,536.97 | 527,536.97 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2011 | -1,414.17% |
| Aug 31, 2011 | -542.31% |
| Nov 30, 2010 | -2,832.84% |
| Aug 31, 2010 | -3,541.80% |